These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

691 related items for PubMed ID: 25981898

  • 1. TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family.
    Kappel S, Janschek E, Wolf B, Rudas M, Teleky B, Jakesz R, Kandioler D.
    Breast Cancer Res Treat; 2015 Jun; 151(3):671-8. PubMed ID: 25981898
    [Abstract] [Full Text] [Related]

  • 2. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW, Verhoef S, Rookus MA, Pruntel R, van der Hout AH, Hogervorst FB, Kluijt I, Sijmons RH, Aalfs CM, Wagner A, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gomez Garcia EB, Meijers-Heijboer H, Ten Kate LP, Menko FH, van 't Veer LJ.
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [Abstract] [Full Text] [Related]

  • 3. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J, Selistre SG, Rossi C, Alemar B, Santos-Silva P, Pereira FS, Netto CB, Cossio SL, Roth DE, Brunetto AL, Zagonel-Oliveira M, Martel-Planche G, Goldim JR, Hainaut P, Camey SA, Ashton-Prolla P.
    Cancer; 2013 Dec 15; 119(24):4341-9. PubMed ID: 24122735
    [Abstract] [Full Text] [Related]

  • 4. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
    Yurgelun MB, Masciari S, Joshi VA, Mercado RC, Lindor NM, Gallinger S, Hopper JL, Jenkins MA, Buchanan DD, Newcomb PA, Potter JD, Haile RW, Kucherlapati R, Syngal S, Colon Cancer Family Registry.
    JAMA Oncol; 2015 May 15; 1(2):214-21. PubMed ID: 26086041
    [Abstract] [Full Text] [Related]

  • 5. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
    Lee DS, Yoon SY, Looi LM, Kang P, Kang IN, Sivanandan K, Ariffin H, Thong MK, Chin KF, Mohd Taib NA, Yip CH, Teo SH.
    Breast Cancer Res; 2012 Apr 16; 14(2):R66. PubMed ID: 22507745
    [Abstract] [Full Text] [Related]

  • 6. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families.
    Llovet P, Illana FJ, Martín-Morales L, de la Hoya M, Garre P, Ibañez-Royo MD, Pérez-Segura P, Caldés T, García-Barberán V.
    Fam Cancer; 2017 Oct 16; 16(4):567-575. PubMed ID: 28573494
    [Abstract] [Full Text] [Related]

  • 7. Transmission of a TP53 germline mutation from unaffected male carrier associated with pediatric glioblastoma in his child and gestational choriocarcinoma in his female partner.
    Cotter JA, Szymanski L, Karimov C, Boghossian L, Margol A, Dhall G, Tamrazi B, Varaprasathan GI, Parham DM, Judkins AR, Biegel JA.
    Cold Spring Harb Mol Case Stud; 2018 Apr 16; 4(2):. PubMed ID: 29581140
    [Abstract] [Full Text] [Related]

  • 8. High frequency of de novo mutations in Li-Fraumeni syndrome.
    Gonzalez KD, Buzin CH, Noltner KA, Gu D, Li W, Malkin D, Sommer SS.
    J Med Genet; 2009 Oct 16; 46(10):689-93. PubMed ID: 19556618
    [Abstract] [Full Text] [Related]

  • 9. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
    Andrade RC, Dos Santos AC, de Aguirre Neto JC, Nevado J, Lapunzina P, Vargas FR.
    Fam Cancer; 2017 Apr 16; 16(2):243-248. PubMed ID: 27714481
    [Abstract] [Full Text] [Related]

  • 10. TP53 germline mutations in adult patients with adrenocortical carcinoma.
    Herrmann LJ, Heinze B, Fassnacht M, Willenberg HS, Quinkler M, Reisch N, Zink M, Allolio B, Hahner S.
    J Clin Endocrinol Metab; 2012 Mar 16; 97(3):E476-85. PubMed ID: 22170717
    [Abstract] [Full Text] [Related]

  • 11. Germ line BAX alterations are infrequent in Li-Fraumeni syndrome.
    Barlow JW, Mous M, Wiley JC, Varley JM, Lozano G, Strong LC, Malkin D.
    Cancer Epidemiol Biomarkers Prev; 2004 Aug 16; 13(8):1403-6. PubMed ID: 15298965
    [Abstract] [Full Text] [Related]

  • 12. TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort.
    Bakhuizen JJ, Hogervorst FB, Velthuizen ME, Ruijs MW, van Engelen K, van Os TA, Gille JJ, Collée M, van den Ouweland AM, van Asperen CJ, Kets CM, Mensenkamp AR, Leter EM, Blok MJ, de Jong MM, Ausems MG.
    Fam Cancer; 2019 Apr 16; 18(2):273-280. PubMed ID: 30607672
    [Abstract] [Full Text] [Related]

  • 13. Drastic effect of germline TP53 missense mutations in Li-Fraumeni patients.
    Zerdoumi Y, Aury-Landas J, Bonaïti-Pellié C, Derambure C, Sesboüé R, Renaux-Petel M, Frebourg T, Bougeard G, Flaman JM.
    Hum Mutat; 2013 Mar 16; 34(3):453-61. PubMed ID: 23172776
    [Abstract] [Full Text] [Related]

  • 14. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.
    Birch JM, Blair V, Kelsey AM, Evans DG, Harris M, Tricker KJ, Varley JM.
    Oncogene; 1998 Sep 03; 17(9):1061-8. PubMed ID: 9764816
    [Abstract] [Full Text] [Related]

  • 15. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
    Achatz MI, Olivier M, Le Calvez F, Martel-Planche G, Lopes A, Rossi BM, Ashton-Prolla P, Giugliani R, Palmero EI, Vargas FR, Da Rocha JC, Vettore AL, Hainaut P.
    Cancer Lett; 2007 Jan 08; 245(1-2):96-102. PubMed ID: 16494995
    [Abstract] [Full Text] [Related]

  • 16. Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome.
    Le AN, Harton J, Desai H, Powers J, Zelley K, Bradbury AR, Nathanson KL, Shah PD, Doucette A, Freedman GM, Gabriel P, Domchek SM, MacFarland SP, Maxwell KN.
    Breast Cancer Res Treat; 2020 May 08; 181(1):181-188. PubMed ID: 32246378
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey.
    Magnusson S, Gisselsson D, Wiebe T, Kristoffersson U, Borg Å, Olsson H.
    Pediatr Blood Cancer; 2012 Nov 08; 59(5):846-53. PubMed ID: 22653678
    [Abstract] [Full Text] [Related]

  • 18. A case of late-onset Li-Fraumeni-like syndrome with unilateral breast cancer.
    Cho Y, Kim J, Kim Y, Jeong J, Lee KA.
    Ann Lab Med; 2013 May 08; 33(3):212-6. PubMed ID: 23667851
    [Abstract] [Full Text] [Related]

  • 19. Two TP53 germline mutations in a classical Li-Fraumeni syndrome family.
    van Hest LP, Ruijs MW, Wagner A, van der Meer CA, Verhoef S, van't Veer LJ, Meijers-Heijboer H.
    Fam Cancer; 2007 May 08; 6(3):311-6. PubMed ID: 17318340
    [Abstract] [Full Text] [Related]

  • 20. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
    Ferreira AM, Brondani VB, Helena VP, Charchar HLS, Zerbini MCN, Leite LAS, Hoff AO, Latronico AC, Mendonca BB, Diz MDPE, de Almeida MQ, Fragoso MCBV.
    J Steroid Biochem Mol Biol; 2019 Jun 08; 190():250-255. PubMed ID: 30974190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.